)
Smith & Nephew (SN) investor relations material
Smith & Nephew Investor update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic growth, vision, and innovation priorities
Focus on four pillars—reach, innovate, scale, and execute efficiently—to drive 6%-7% organic revenue growth and 9%-13% trading profit growth over the next three years, targeting over $1 billion in free cash flow and 12%-13% ROIC by 2028.
RISE strategy emphasizes efficient execution, strategic investment, and expanding patient reach to improve margins and returns.
Robust product pipeline with increased launch cadence from 2026-2028 across orthopaedics, sports medicine, and wound management.
R&D investment is increasing, especially in sports medicine and wound care, with 44 products launched in the past three years and plans for 14-16 new launches annually through 2026.
Major scalable technology platforms include MTECH, TESSA, Lumos, and a rapidly evolving robotic platform.
Advanced wound management and innovation
Broad portfolio targets high-growth segments like pressure injury prevention, chronic wounds, and surgical site complications, with products such as LEAF, ALLEVYN COMPLETE CARE, and ALLEVYN Ag+ Surgical.
LEAF reduces pressure injury risk by 94%, while ALLEVYN COMPLETE CARE offers superior exudate management and flexibility.
PICO, a portable single-use negative pressure wound therapy device, reduces surgical site complications by up to 63% and length of stay by 1.75 days.
Over 200 patents and 310 studies, including 60 RCTs, support PICO's effectiveness; NICE recommends its use.
Continued investment in PICO aims to expand patient reach and accelerate innovation.
Sports medicine and biologics
REGENETEN bioinductive implant reduces rotator cuff re-tear rates by 65% at two years and is expanding to extra-articular ligaments.
CARTIHEAL AGILI-C implant provides twice the pain reduction of microfracture and reduces risk of knee replacement by over 80%, with durable 5-year outcomes.
TESSA introduces real-time, video-based navigation for arthroscopic surgery, enhancing ACL reconstruction accuracy and expanding future applications.
Tendon Seam offers stronger, more stable repairs, minimizing gap formation and supporting healing.
- Q1 2026 saw 3.1% underlying revenue growth and a $500m share buyback announcement.SN
Investor presentation27 May 2026 - Q1 2026 delivered 3.1% underlying growth, guidance reaffirmed, and a $500M buyback announced.SN
Q1 2026 TU12 May 2026 - Strong FY 2025 growth, margin expansion, and new strategy set stage for accelerated 2026 performance.SN
Investor presentation16 Mar 2026 - Strong FY2025 growth, margin expansion, and cash flow set up for accelerated 2026 performance.SN
Q4 20252 Mar 2026 - RISE strategy drives growth, innovation, and ASC leadership with strong financial targets for 2028.SN
CMD 20253 Feb 2026 - Q2 revenue up 5.6%, margin and cash flow improved, guidance and dividend maintained.SN
H1 20242 Feb 2026 - Q3 revenue up 4.0%, but China headwinds prompt lower 2024 margin and growth guidance.SN
Q3 2024 TU17 Jan 2026 - Strong growth, margin expansion, and cash flow improvement, with China as a key headwind.SN
H2 20247 Jan 2026 - Q1 2025 revenue grew 3.1% with innovation and margin guidance unchanged despite headwinds.SN
Q1 2025 TU21 Dec 2025
Next Smith & Nephew earnings date
Next Smith & Nephew earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)